Temozolomide and cisplatin in relapsed/refractory acute leukemia

Overview of attention for article published in Journal of Hematology & Oncology, May 2009

Altmetric Badge

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity

Article in Cancers (December 2022)

RETRACTED ARTICLE: MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4

Article in Bioengineered (October 2021)

Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation

Article in Biomedicine & Pharmacotherapy (September 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.